Thursday, November 09, 2017 9:31:31 AM
Just think... it took them two quarters... to even higher the way extra 35 sales people... They talked about it two CC ago.. !!
And as I have been saying here BRLI.. IS A BALL AND CHAIN around our necks... The stock was closer to like 18 when they decided to buy it.. and DOWN EVER SINCE.. I don't see this.. I don't know what... TEAM.. running a business like BRLI.. and doing a good job... IMO... THEY HAVEN'T DONE IT YET.. IMO>>.. THEY ARE LEARNING THE BUSINESS AS THEY RUN THE BUSINESS... !! INSTEAD OF BRINGING IN TOP MANAGEMENT WHO KNOWS HOW TO RUN SUCH A BUSINESS...
Frost should resign.. Been saying that.. How do shareholders like that he stopped buying in end of September... And the stock has gone down since ???? I mean... DUH.. think he knew he was going to have a bad 3rd quarter??? and thought.. I can buy more a lot cheaper !!!??????????????
And great all those PAID... MD's.. there for questions.. and they do what?? and make what?? This seems more and more like a Good old Boy run Place... !!
And as I have been saying here BRLI.. IS A BALL AND CHAIN around our necks... The stock was closer to like 18 when they decided to buy it.. and DOWN EVER SINCE.. I don't see this.. I don't know what... TEAM.. running a business like BRLI.. and doing a good job... IMO... THEY HAVEN'T DONE IT YET.. IMO>>.. THEY ARE LEARNING THE BUSINESS AS THEY RUN THE BUSINESS... !! INSTEAD OF BRINGING IN TOP MANAGEMENT WHO KNOWS HOW TO RUN SUCH A BUSINESS...
Frost should resign.. Been saying that.. How do shareholders like that he stopped buying in end of September... And the stock has gone down since ???? I mean... DUH.. think he knew he was going to have a bad 3rd quarter??? and thought.. I can buy more a lot cheaper !!!??????????????
And great all those PAID... MD's.. there for questions.. and they do what?? and make what?? This seems more and more like a Good old Boy run Place... !!
Recent OPK News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/15/2026 08:38:03 PM
- OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies • GlobeNewswire Inc. • 05/12/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 08:04:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:01:43 PM
- OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China • GlobeNewswire Inc. • 04/30/2026 12:30:00 PM
- BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform • GlobeNewswire Inc. • 04/30/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:06:14 PM
- OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results • GlobeNewswire Inc. • 04/28/2026 08:05:00 PM
- OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas • GlobeNewswire Inc. • 04/22/2026 12:00:00 PM
- OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 • GlobeNewswire Inc. • 04/21/2026 08:05:00 PM
- OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19 • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:25:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:16:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:50:09 PM
- OPKO Health to Participate in the Jefferies Biotech on the Beach Summit • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:07:43 PM
- OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results • GlobeNewswire Inc. • 02/26/2026 09:05:00 PM
- OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 • GlobeNewswire Inc. • 02/12/2026 01:00:00 PM
- OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism • GlobeNewswire Inc. • 02/04/2026 01:00:00 PM
- OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/06/2026 09:11:42 PM
- OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference • GlobeNewswire Inc. • 11/19/2025 09:05:00 PM
- NextPlat Reports Third Quarter 2025 Results • PR Newswire (US) • 11/13/2025 01:03:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/29/2025 08:12:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2025 08:11:05 PM
